Adverse Event Clinical Trials

8 recruiting

Adverse Event Trials at a Glance

36 actively recruiting trials for adverse event are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Boston. Lead sponsors running adverse event studies include AHS Cancer Control Alberta, University of Queensland, and Beijing 302 Hospital.

Browse adverse event trials by phase

Treatments under study

About Adverse Event Clinical Trials

Looking for clinical trials for Adverse Event? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adverse Event trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adverse Event clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 36 trials

Recruiting
Not Applicable

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

Adverse EventMultiple Chronic Conditions
Brigham and Women's Hospital1,300 enrolled2 locationsNCT05282654
Recruiting
Phase 4

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Perioperative Respiratory Adverse EventsRespiratory HypersensitivityAnticholinergics+1 more
Sun Yat-sen University204 enrolled2 locationsNCT06624696
Recruiting
Not Applicable

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

Health DisparitiesPatient SafetyQuality Improvement+3 more
Boston Children's Hospital656 enrolled1 locationNCT05407129
Recruiting
Not Applicable

TEAS for Sedation During ERCP: A Multicenter Trial

Procedural PainEndoscopic Retrograde CholangiopancreatographyConscious Sedation Adverse Event+1 more
Beijing 302 Hospital130 enrolled1 locationNCT07440342
Recruiting
Phase 2

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta94 enrolled1 locationNCT06860542
Recruiting
Phase 4

Safety of RSV Preventive Monoclonal Antibody

FeverAdverse Event Following Immunisation
Duke University524 enrolled6 locationsNCT07158814
Recruiting

Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III

Adverse EventsAirway Complication of Anesthesia
Insel Gruppe AG, University Hospital Bern40,000 enrolled5 locationsNCT06117176
Recruiting
Phase 2

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811
Recruiting
Not Applicable

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Quality of LifeObjective Response RatePathological Complete Remission+1 more
The Second Hospital of Shandong University25 enrolled1 locationNCT07430579
Recruiting

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

CancerCancer;Cardiovascular;Adverse Events
Sixth Affiliated Hospital, Sun Yat-sen University5,000 enrolled1 locationNCT07058454
Recruiting
Phase 4

Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.

Perioperative Respiratory Adverse EventsAnesthesia Outcomes
Telethon Kids Institute200 enrolled1 locationNCT07000877
Recruiting

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Adverse EventAcute Myocardial Infarction
Yu Bo15,000 enrolled18 locationsNCT05862103
Recruiting
Not Applicable

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Peritoneal DialysisAdverse EventModerate-to-severe Pruritus+1 more
Guangdong Provincial People's Hospital93 enrolled1 locationNCT07098351
Recruiting
Phase 2

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

Advanced MelanomaDiarrheaImmune-related Adverse Event+1 more
AHS Cancer Control Alberta20 enrolled1 locationNCT05663775
Recruiting
Not Applicable

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse Event+1 more
Centre Hospitalier Universitaire, Amiens150 enrolled1 locationNCT05813418
Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

Adverse EventsIntubation Complication
Thomas Riva105,000 enrolled8 locationsNCT05804188
Recruiting

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

Gastric CancerImmunotherapyAdverse Event+2 more
Qinghai Red Cross Hospital100 enrolled1 locationNCT06915389
Recruiting
Not Applicable

ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery

Adverse EventsSpine DeformityBone Graft; Complications
Rigshospitalet, Denmark240 enrolled1 locationNCT05038527
Recruiting
Not Applicable

Food Intervention to Reduce Immunotherapy ToXicity

Immune-related Adverse EventDietary Habits
Universitair Ziekenhuis Brussel60 enrolled1 locationNCT05832606
Recruiting
Phase 4

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Blood PressureDiabetes Mellitus, Type 2Adverse Event+2 more
XueQing Yu11,414 enrolled1 locationNCT03264352